US equities
|
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about hereditary angioedema
Recent news which mentions hereditary angioedema
Intellia To Test Second CRISPR Therapeutic In Hereditary Angioedema Patients
October 06, 2021
Tickers
NTLA
Tags
Gene Editing
FDA
News
From
Benzinga
NICE Recommends BioCryst's Hereditary Angioedema Med
September 16, 2021
Tickers
BCRX
Tags
FDA
Market News
News
From
Benzinga
FDA Lifts Clinical Hold On KalVista's Hereditary Angioedema Trial
September 14, 2021
Tickers
KALV
Tags
Movers
Biotech
Benzinga
From
Benzinga
BioCryst Shares 96-Week Orladeyo Data Highlighting 80% Reduction In HAE Attacks
July 12, 2021
Tickers
BCRX
Tags
News
Market News
hereditary angioedema
From
Benzinga